Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 FY- Text added to 2017 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
Academy, Accelera, accelerate, acceleration, Achillion, Adlai, al, Allovectin, Amgen, Andrew, Aon, approach, Aranesp, arm, ascribed, basket, billed, biochemistry, Biogen, biopharma, blockade, blockbuster, bolstered, Brown, BSc, California, capturing, Celgene, Chartered, Chevalier, Chile, China, Chinese, constraining, core, CryptoMedicx, daily, Deborah, Diego, discovering, doctorate, economy, EMA, EMBO, EMD, Enbrel, Epogen, Fame, fellowship, fifteen, fiftieth, FluMist, founder, Gairdner, geopolitical, Governor, Guelph, Guttadauro, Halifax, Hall, hazard, Hewitt, Hong, hormone, Howlader, HR, Idec, Immunovaccine, Indian, inducted, influenza, inhaled, input, INSEAD, instability, Intriguingly, Ivey, Jamieson, Journal, Kellogg, Kong, Korea, laid, launch, Lupron, Macau, MAP, mbc, median, MedImmune, Merck, metabolic, Michigan, Military, mOS, Nadia, Neuroimmunology, NJ, noncurrent, Northwestern, Nortye, occurrence, OS, parallel, partial, PCAOB, PharmaTech, pipeline, Plant, PLC, political, predominant, premium, prepaid, Prevacid, prevalence, Princeton, programme, PSU, Quest, Radford, radioimmunotherapy, ratio, recognised, recognising, redacted, regional, regualtory, resolved, Serono, Shantha, Singapore, South, SPCA, specialty, stable, subgroup, subtype, Taiwan, TAP, tenure, terrorism, traditional, trainee, underwritten, uneven, upfront, Vaccibody, Vical, war, West, whichever, Zevalin
Removed:
AstraZeneca, author, book, Bray, CancerBase, chemistry, Cincinnati, Dean, Dickinson, Dikshit, Dinning, DM, Epilepsy, Ervik, Eser, Ferlay, forecast, Forman, globocan, iarc, ICI, Ligand, lung, Lyon, Manhattan, MHRA, mortality, Mt, Neurology, Parkin, Pennsylvania, Philadelphia, privately, professor, Rebelo, Residency, resignation, Roche, Schultz, Sinai, Soerjomataram, Southern, stating, thirty, VaxInnate, VP, women, Xmark
Valuein 2016 FY filing- Value in 2017 FY filing
Original filings
Filing view